Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Owyong

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMC Cancer|June 12, 2020
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic targetCatharina Hagerling, Mark Owyong, Vaishnavi Sitarama, et al.
Immunity|March 1, 2025
Splenic TNF-α signaling potentiates the innate-to-adaptive transition of antiviral NK cellsAdriana M Mujal, Mark Owyong, Endi K Santosa, et al.
Immunity|January 31, 2026
Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytesSimon Grassmann, Endi K Santosa, Hyunu Kim, et al.
Life Science Alliance|November 16, 2019
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapyMark Owyong, Jonathan Chou, Renske Je van den Bijgaart, et al.
Cell|July 1, 2026
LEF1 and niche factors determine T cell stemness across chronic diseasesSvetlana Miakicheva, Katrina M Hawley, Paul Zumbo, et al.
Nature Communications|September 23, 2023
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancerLucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fateAlexia Martínez de Paz, Christopher R Chin, Mythili Ketavarapu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMC Cancer|June 12, 2020
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic targetCatharina Hagerling, Mark Owyong, Vaishnavi Sitarama, et al.
Immunity|March 1, 2025
Splenic TNF-α signaling potentiates the innate-to-adaptive transition of antiviral NK cellsAdriana M Mujal, Mark Owyong, Endi K Santosa, et al.
Immunity|January 31, 2026
Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytesSimon Grassmann, Endi K Santosa, Hyunu Kim, et al.
Life Science Alliance|November 16, 2019
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapyMark Owyong, Jonathan Chou, Renske Je van den Bijgaart, et al.
Cell|July 1, 2026
LEF1 and niche factors determine T cell stemness across chronic diseasesSvetlana Miakicheva, Katrina M Hawley, Paul Zumbo, et al.
Nature Communications|September 23, 2023
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancerLucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fateAlexia Martínez de Paz, Christopher R Chin, Mythili Ketavarapu, et al.
Pageof 2